Trials / Unknown
UnknownNCT04751422
Medical Data Collection for the Evaluation of Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine
A Single-Center Retrospective Study Evaluating Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study collects data on the use of radiofrequency ablation and cement augmentation for the treatment of cancer that has spread to the spine (metastases to the spine). Radiofrequency ablation with cement augmentation is a useful approach for the treatment of secondary metastasis to the spine. Information collected in this study may help doctors to learn the effectiveness of this therapy, and may help to evaluate optimal technique, appropriate patient selection, and management of complications.
Detailed description
PRIMARY OBJECTIVE: I. To evaluate the use of radiofrequency ablation and cement augmentation for the treatment of secondary metastases to the spine. OUTLINE: Patients' medical data is collected retrospectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Electronic Health Record Review | Medical data is collected |
Timeline
- Start date
- 2020-11-13
- Primary completion
- 2023-09-30
- Completion
- 2023-09-30
- First posted
- 2021-02-12
- Last updated
- 2023-04-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04751422. Inclusion in this directory is not an endorsement.